Civil Action No. 18-2394 (RDM).

369 F.Supp.3d 183 (2019)

TEVA PHARMACEUTICALS USA, INC., Plaintiff, v. Alex M. AZAR, II et al., Defendants.

United States District Court, District of Columbia.

Signed February 26, 2019.

Editors Note
Applicable Law: 05 U.S.C. § 702
Cause: 05 U.S.C. § 702 Administrative Procedure Act
Nature of Suit: 899 Administrative Procedure Act / Review or Appeal of Agency Decision
Source: PACER

Attorney(s) appearing for the Case

Michael D. Shumsky , Jennifer McVey Thomas , Kurt R. Karst , Hyman, Phelps & McNamara, P.C., Thomas J. Tobin , Kirkland & Ellis LLP, Washington, DC, for Plaintiff.

Charles John Biro , U.S. Department of Justice, Washington, DC, for Defendants.


Plaintiff Teva Pharmaceuticals USA, Inc. ("Teva") brings this action to obtain "immediate injunctive and declaratory relief" barring the Food and Drug Administration ("FDA") from "depriving [Teva] of its statutory right to 180 days of marketing exclusivity...

Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases